Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 7Breast Neoplasms 4Peripheral Nervous System Diseases 2Squamous Cell Carcinoma of Head and Neck 1Radiodermatitis 1Primary Ovarian Insufficiency 1Ototoxicity 1Neurotoxicity Syndromes 1Nervous System Diseases 1Mucositis 1Insulin Resistance 1Infertility, Female 1Infertility 1Hyperandrogenism 1Head and Neck Neoplasms 1Disease Progression 1Cisplatin Nephrotoxicity 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Female 1

Interventions

Metformin 30Exercise 8Pioglitazone 7Inositol 6Insulin 4Acupuncture Therapy 4High-Intensity Interval Training 3Ethinyl Estradiol 3salicylsalicylic acid 2drospirenone and ethinyl estradiol combination 2Water 2Tablets 2Sugars 2Resistance Training 2Preoperative Exercise 2Folic Acid 2Diet Therapy 2Cyproterone Acetate 2Caloric Restriction 2Biguanides 2ziprasidone 1maltodextrin 1lime 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1adrenosterone 1Zoledronic Acid 1World Health Organization oral rehydration solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Insulin Resistance × Thioctic Acid × Clear all
NCT00505427 2013-07-01

Alpha Lipoic Acid and Polycystic Ovary Syndrome

University of California, San Francisco

Phase 1 Completed
22 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡